Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species

Several promising antimalarial drugs are currently being tested in human trials, such as artefenomel, cipargamin, ferroquine and ganaplacide. Many of these compounds were identified using high throughput screens against a single species of human malaria, Plasmodium falciparum, under the assumption t...

Full description

Saved in:
Bibliographic Details
Published in:Int J Parasitol Drugs Drug Resist
Main Authors: van Schalkwyk, Donelly A., Moon, Robert W., Duffey, Maëlle, Leroy, Didier, Sutherland, Colin J.
Format: Artigo
Language:Inglês
Published: Elsevier 2021
Subjects:
Regular article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327131/
https://ncbi.nlm.nih.gov/pubmed/34315108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.07.002
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items